Stability of cefonicid sodium in infusion fluids. 1985

W W Wong, and A B Maderich, and G P Polli, and L J Ravin

The chemical stability of cefonicid sodium in infusion fluids was analyzed. Cefonicid sodium vials were reconstituted and diluted with sterile water for injection and other commonly used intravenous fluids to concentrations of 325, 220, 40, 20, and 5 mg/mL. Cefonicid concentration was analyzed by high-performance liquid chromatography initially and after storage at room temperature and 5 degrees C. Reconstituted vials were frozen as long as eight weeks, thawed, and kept at room temperature and 5 degrees C and then analyzed. Cefonicid sodium reconstituted in each of the diluents studied exhibited no change in clarity and very little change in potency after 24 hours at room temperature and after 72 hours at 5 degrees C. Some vials with high concentrations became turbid between 72 and 96 hours at 5 degrees C. The thawed vials were chemically stable for 24 hours at room temperature and for 96 hours at 5 degrees C. When reconstituted with sterile water for injection and other commonly used intravenous fluids, cefonicid sodium vials and small-volume infusions are chemically stable for 24 hours at room temperature and for 72 hours at 5 degrees C. Reconstituted cefonicid sodium vials can be frozen and stored for as long as eight weeks, thawed, and then kept at room temperature for 24 hours or at 5 degrees C for 72 hours.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015790 Cefonicid A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. Cefonicid Disodium Salt,Cefonicid Monosodium,Cefonicid Monosodium Salt,Monocid,SK&F-75073,SKF-75073-2,Sodium Cefonicid,Cefonicid, Sodium,SK&F 75073,SK&F75073,SKF 75073 2,SKF750732

Related Publications

W W Wong, and A B Maderich, and G P Polli, and L J Ravin
December 1982, Journal of clinical and hospital pharmacy,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
June 1984, American journal of hospital pharmacy,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
July 1984, American journal of hospital pharmacy,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
August 1984, The Medical letter on drugs and therapeutics,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
May 1993, The Journal of pharmacy and pharmacology,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
January 1985, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
April 1981, American journal of hospital pharmacy,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
July 1981, American journal of hospital pharmacy,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
November 1990, DICP : the annals of pharmacotherapy,
W W Wong, and A B Maderich, and G P Polli, and L J Ravin
January 1988, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
Copied contents to your clipboard!